Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed May 14, 2026 · 10-Q · 44 days after period end · 0001493152-26-023140
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$4.11M | -$4.99M | -$7.23M | -$6.46M |
| EPS Diluted | -$0.43 | -$2.21 | -$2.03 | -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end
